UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Sigma Investment Counselors Inc.

Sigma Investment Counselors Inc. lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 14,729 shares of the healthcare conglomerate’s stock after selling 296 shares during the quarter. Sigma Investment Counselors Inc.’s holdings in UnitedHealth Group were worth $7,451,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Lansing Street Advisors raised its stake in UnitedHealth Group by 3.7% in the 4th quarter. Lansing Street Advisors now owns 766 shares of the healthcare conglomerate’s stock valued at $388,000 after purchasing an additional 27 shares during the last quarter. Howard Capital Management Inc. raised its stake in UnitedHealth Group by 0.8% in the 4th quarter. Howard Capital Management Inc. now owns 7,925 shares of the healthcare conglomerate’s stock valued at $4,009,000 after purchasing an additional 65 shares during the last quarter. Integral Investment Advisors Inc. raised its stake in UnitedHealth Group by 3.5% in the 4th quarter. Integral Investment Advisors Inc. now owns 1,015 shares of the healthcare conglomerate’s stock valued at $513,000 after purchasing an additional 34 shares during the last quarter. Wealthspire Advisors LLC raised its stake in UnitedHealth Group by 4.6% in the 4th quarter. Wealthspire Advisors LLC now owns 13,977 shares of the healthcare conglomerate’s stock valued at $7,070,000 after purchasing an additional 614 shares during the last quarter. Finally, FPC Investment Advisory Inc. raised its stake in UnitedHealth Group by 863.6% in the 4th quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock valued at $58,000 after purchasing an additional 95 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on UNH. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Wells Fargo & Company lowered their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Down 7.3 %

Shares of NYSE:UNH opened at $465.58 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a 50 day moving average of $519.27 and a two-hundred day moving average of $560.48. The company has a market capitalization of $428.46 billion, a price-to-earnings ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the company earned $5.83 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.